These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18693236)

  • 21. IPSAT P1A, a class A beta-lactamase therapy for the prevention of penicillin-induced disruption to the intestinal microflora.
    Pitout JD
    Curr Opin Investig Drugs; 2009 Aug; 10(8):838-44. PubMed ID: 19649928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relapsing Clostridium difficile toxin-associated colitis in ovarian cancer patients treated with chemotherapy.
    Satin AJ; Harrison CR; Hancock KC; Zahn CM
    Obstet Gynecol; 1989 Sep; 74(3 Pt 2):487-9. PubMed ID: 2761938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of ampicillin-induced emergence of resistance in intestinal coliforms by targeted recombinant beta-lactamase.
    Mentula S; Harmoinen J; Koski P; Westermarck E; Rautio M; Huovinen P; Könönen E
    Int J Antimicrob Agents; 2004 Dec; 24(6):555-61. PubMed ID: 15555877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What is on that keyboard? Detecting hidden environmental reservoirs of Clostridium difficile during an outbreak associated with North American pulsed-field gel electrophoresis type 1 strains.
    Dumford DM; Nerandzic MM; Eckstein BC; Donskey CJ
    Am J Infect Control; 2009 Feb; 37(1):15-9. PubMed ID: 19171247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New trends in Clostridium difficile virulence and pathogenesis.
    Denève C; Janoir C; Poilane I; Fantinato C; Collignon A
    Int J Antimicrob Agents; 2009 Mar; 33 Suppl 1():S24-8. PubMed ID: 19303565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clostridium difficile infections in a Shanghai hospital: antimicrobial resistance, toxin profiles and ribotypes.
    Huang H; Wu S; Wang M; Zhang Y; Fang H; Palmgren AC; Weintraub A; Nord CE
    Int J Antimicrob Agents; 2009 Apr; 33(4):339-42. PubMed ID: 19097757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A simple 3-step algorithm for improved laboratory detection of Clostridium difficile toxin without the need for tissue culture cytotoxicity neutralization assays.
    Sharp SE; Ivie WM; Buckles MR; Coover DM; Pohl JC; Hatcher PA
    Diagn Microbiol Infect Dis; 2009 Jul; 64(3):344-6. PubMed ID: 19376666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vegetative Clostridium difficile survives in room air on moist surfaces and in gastric contents with reduced acidity: a potential mechanism to explain the association between proton pump inhibitors and C. difficile-associated diarrhea?
    Jump RL; Pultz MJ; Donskey CJ
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2883-7. PubMed ID: 17562803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of vancomycin against epidemic Clostridium difficile strains in a human gut model.
    Baines SD; O'Connor R; Saxton K; Freeman J; Wilcox MH
    J Antimicrob Chemother; 2009 Mar; 63(3):520-5. PubMed ID: 19112083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective study of the risk of Clostridium difficile diarrhoea in elderly patients following treatment with cefotaxime or piperacillin-tazobactam.
    Settle CD; Wilcox MH; Fawley WN; Corrado OJ; Hawkey PM
    Aliment Pharmacol Ther; 1998 Dec; 12(12):1217-23. PubMed ID: 9882029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of Clostridium difficile strains isolated from immunosuppressed inpatients in a hospital in Rio de Janeiro, Brazil.
    Balassiano IT; Miranda KR; Boente RF; Pauer H; Oliveira IC; Santos-Filho J; Amorim EL; Caniné GA; Souza CF; Gomes MZ; Ferreira EO; Brazier JS; Domingues RM
    Anaerobe; 2009 Jun; 15(3):61-4. PubMed ID: 19154793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of fatal Clostridium difficile-associated disease during continuous administration of clindamycin in hamsters.
    Merrigan MM; Sambol SP; Johnson S; Gerding DN
    J Infect Dis; 2003 Dec; 188(12):1922-7. PubMed ID: 14673773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colonization for the prevention of Clostridium difficile disease in hamsters.
    Sambol SP; Merrigan MM; Tang JK; Johnson S; Gerding DN
    J Infect Dis; 2002 Dec; 186(12):1781-9. PubMed ID: 12447764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of the large bowel microbiota of colitic mice using PCR/DGGE.
    Bibiloni R; Simon MA; Albright C; Sartor B; Tannock GW
    Lett Appl Microbiol; 2005; 41(1):45-51. PubMed ID: 15960751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of porcine Clostridium difficile-associated disease by competitive exclusion with nontoxigenic organisms.
    Songer JG; Jones R; Anderson MA; Barbara AJ; Post KW; Trinh HT
    Vet Microbiol; 2007 Oct; 124(3-4):358-61. PubMed ID: 17493774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacillus amyloliquefaciens as prophylactic treatment for Clostridium difficile-associated disease in a mouse model.
    Geeraerts S; Ducatelle R; Haesebrouck F; Van Immerseel F
    J Gastroenterol Hepatol; 2015 Aug; 30(8):1275-80. PubMed ID: 25800047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clostridium difficile in preterm neonates.
    Cardines R; Luzzi I; Menichella G; Virgili Q; Mastrantonio P
    Microbiologica; 1988 Jul; 11(3):259-61. PubMed ID: 3173125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Orally administered targeted recombinant Beta-lactamase prevents ampicillin-induced selective pressure on the gut microbiota: a novel approach to reducing antimicrobial resistance.
    Harmoinen J; Mentula S; Heikkilä M; van der Rest M; Rajala-Schultz PJ; Donskey CJ; Frias R; Koski P; Wickstrand N; Jousimies-Somer H; Westermarck E; Lindevall K
    Antimicrob Agents Chemother; 2004 Jan; 48(1):75-9. PubMed ID: 14693521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Epidemiological study of Clostridium difficile strains isolated in Jean-Verdier-René-Muret hospitals from 2001 to 2007].
    Poilane I; Fantinato C; Cruaud P; Collignon A
    Pathol Biol (Paris); 2008; 56(7-8):412-6. PubMed ID: 18842360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased susceptibility to vancomycin-resistant Enterococcus intestinal colonization persists after completion of anti-anaerobic antibiotic treatment in mice.
    Stiefel U; Pultz NJ; Helfand MS; Donskey CJ
    Infect Control Hosp Epidemiol; 2004 May; 25(5):373-9. PubMed ID: 15188841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.